Valentin Garcia
Hematology Unit, Hospital Universitario Ramón y Cajal, Madrid (Spain) · Hospital Ramon y Cajal · Hospital Universitario Ramon y Cajal
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Valentin Garcia as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-11 21:38 UTC. Open this list on ClinicalTrials.gov
- Ph2NCT06409936 · PEARL Study: PotEntial of Asciminib in the eaRly Treatment of CMLGruppo Italiano Malattie EMatologiche dell'Adulto · recruiting · CML, Chronic Phase, Chronic Myeloid Leukemia, Chronic Phase, Chronic Myeloid Leukemia, BCR/ABL-Positive · principal investigator
- Ph1/Ph2NCT04793399 · Safety and Efficacy Evaluation of Bosutinib Plus Atezolizumab in Newly Diagnosed Chronic Leukemia Adult PatientsFundacion Espanola para la Curacion de la Leucemia Mieloide Cronica · terminated · Chronic Phase-Chronic Myeloid Leukemia · principal investigator
- Ph2NCT04043676 · Consolidation Treatment With Ponatinib 15 mg on Treatment Free-Remission Rate in Patients With Chronic Myeloid LeukemiaFundación Teófilo Hernando, Spain · unknown · Chronic Myeloid Leukemia · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-11 21:38 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
Clinical-trial papers with this author name, ranked by citations from NIH iCite, fetched 2026-11-11 21:38 UTC. The ranking covers the 200 most relevant of 79 PubMed records, and a shared surname and initials can bring in a namesake. All 79 on PubMed
- A phase III study of belatacept versus cyclosporine in kidney transplants from extended criteria donors (BENEFIT-EXT study).Am J Transplant · 2010460 citationsRCR 13.1
- Treatment of Knee Osteoarthritis With Allogeneic Bone Marrow Mesenchymal Stem Cells: A Randomized Controlled Trial.Transplantation · 2015454 citationsRCR 20.0
- Three-year outcomes from BENEFIT, a randomized, active-controlled, parallel-group study in adult kidney transplant recipients.Am J Transplant · 2012250 citationsRCR 7.8
- Everolimus with optimized cyclosporine dosing in renal transplant recipients: 6-month safety and efficacy results of two randomized studies.Am J Transplant · 2004203 citationsRCR 6.1
- Three-year outcomes from BENEFIT-EXT: a phase III study of belatacept versus cyclosporine in recipients of extended criteria donor kidneys.Am J Transplant · 2012198 citationsRCR 6.7
- Intervertebral Disc Repair by Allogeneic Mesenchymal Bone Marrow Cells: A Randomized Controlled Trial.Transplantation · 2017197 citationsRCR 10.2
- Switching from calcineurin inhibitor-based regimens to a belatacept-based regimen in renal transplant recipients: a randomized phase II study.Clin J Am Soc Nephrol · 2011159 citationsRCR 5.0
- Clinical efficacy of a xenogeneic collagen matrix in augmenting keratinized mucosa around implants: a randomized controlled prospective clinical trial.Clin Oral Implants Res · 2012144 citationsRCR 7.6
- IL-17 and IFN-γ expression in lymphocytes from patients with active tuberculosis correlates with the severity of the disease.J Leukoc Biol · 2012138 citationsRCR 3.7
- Clinical and microbiological effects of photodynamic therapy associated with nonsurgical periodontal treatment. A 6-month follow-up.Lasers Med Sci · 201299 citationsRCR 5.3